Suppr超能文献

- 具有更高效力和稳定性的靶向活性可溶性环氧水解酶的PROTACs。

-Active Soluble Epoxide Hydrolase-Targeting PROTACs with Improved Potency and Stability.

作者信息

Nakane Keita, Morisseau Christophe, Dowker-Key Presley D, Benitez Gabrielle, Aguilan Jennifer T, Nagai Emiko, Sidoli Simone, Hammock Bruce D, Bettaieb Ahmed, Shinoda Kosaku, Kitamura Seiya

机构信息

Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, United States.

Department of Entomology and Nematology, and UC Davis Comprehensive Cancer Center, University of California, One Shields Avenue, Davis, California 95616, United States.

出版信息

ACS Med Chem Lett. 2024 Oct 3;15(11):1891-1898. doi: 10.1021/acsmedchemlett.4c00357. eCollection 2024 Nov 14.

Abstract

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme involved in fatty acid metabolism and a promising drug target. We previously reported first-generation sEH proteolysis-targeting chimeras (PROTACs) with limited degradation potency and low aqueous and metabolic stability. Herein, we report the development of next-generation sEH PROTAC molecules with improved stability and degradation potency. One of the most potent molecules (compound ) exhibits a half-maximal degradation concentration in the sub-nM range, is stable , and effectively degrades sEH in mouse livers and brown adipose tissues. Given the role played by sEH in many metabolic and nonmetabolic diseases, the presented molecules provide useful chemical probes for the study of sEH biology. They also hold potential for therapeutic development against a range of disease conditions, including diabetes, inflammation, and metabolic disorders.

摘要

可溶性环氧化物水解酶(sEH)是一种参与脂肪酸代谢的双功能酶,也是一个很有前景的药物靶点。我们之前报道过第一代sEH蛋白水解靶向嵌合体(PROTACs),其降解效力有限,且在水性和代谢方面稳定性较低。在此,我们报道了具有更高稳定性和降解效力的下一代sEH PROTAC分子的研发情况。其中最有效的一种分子(化合物 )在亚纳摩尔范围内表现出半数最大降解浓度,稳定性良好,并且能在小鼠肝脏和棕色脂肪组织中有效降解sEH。鉴于sEH在许多代谢性和非代谢性疾病中所起的作用,所展示的这些分子为研究sEH生物学提供了有用的化学探针。它们在针对一系列疾病状况(包括糖尿病、炎症和代谢紊乱)的治疗开发方面也具有潜力。

相似文献

1
-Active Soluble Epoxide Hydrolase-Targeting PROTACs with Improved Potency and Stability.
ACS Med Chem Lett. 2024 Oct 3;15(11):1891-1898. doi: 10.1021/acsmedchemlett.4c00357. eCollection 2024 Nov 14.
2
-Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability.
bioRxiv. 2024 Jul 24:2024.07.23.604814. doi: 10.1101/2024.07.23.604814.
3
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase.
J Med Chem. 2025 Jul 10;68(13):13728-13749. doi: 10.1021/acs.jmedchem.5c00552. Epub 2025 Jun 18.
6
Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.
Future Med Chem. 2025 Jul 16:1-13. doi: 10.1080/17568919.2025.2533113.
8
PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction.
ACS Chem Biol. 2023 Apr 21;18(4):884-896. doi: 10.1021/acschembio.3c00017. Epub 2023 Mar 22.

本文引用的文献

1
Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress.
Biomed Pharmacother. 2023 Dec;168:115667. doi: 10.1016/j.biopha.2023.115667. Epub 2023 Oct 10.
2
PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction.
ACS Chem Biol. 2023 Apr 21;18(4):884-896. doi: 10.1021/acschembio.3c00017. Epub 2023 Mar 22.
3
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design.
ACS Med Chem Lett. 2023 Jan 4;14(2):141-145. doi: 10.1021/acsmedchemlett.2c00436. eCollection 2023 Feb 9.
4
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs.
Angew Chem Int Ed Engl. 2021 Dec 13;60(51):26663-26670. doi: 10.1002/anie.202108848. Epub 2021 Nov 16.
7
Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21576-21587. doi: 10.1073/pnas.2007412117. Epub 2020 Aug 14.
9
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.
Proc Natl Acad Sci U S A. 2018 May 15;115(20):5283-5288. doi: 10.1073/pnas.1721711115. Epub 2018 May 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验